Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank71
3Y CAGR-6.8%
5Y CAGR+10.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-6.8%/yr
Annual compound
5Y CAGR
+10.7%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.10 | +133.9% |
| 2024 | -0.29 | -339.0% |
| 2023 | 0.12 | -0.0% |
| 2022 | 0.12 | +54.7% |
| 2021 | 0.08 | +32.4% |
| 2020 | 0.06 | +126.8% |
| 2019 | -0.22 | +78.1% |
| 2018 | -1.01 | - |